-
Product Insights
Hyperphosphatemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Hyperphosphatemia - Drugs In Development, 2023’, provides an overview of the Hyperphosphatemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperphosphatemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Rickets – Drugs In Development, 2023
Global Markets Direct’s, ‘Rickets - Drugs In Development, 2023’, provides an overview of the Rickets pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rickets, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Vitamin D Deficiency Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Vitamin D Deficiency Disorders - Drugs In Development, 2023’, provides an overview of the Vitamin D Deficiency Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vitamin D Deficiency Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Hyperphosphatemia In Chronic Kidney Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Drugs In Development, 2023’, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperphosphatemia In Chronic Kidney Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
X-Linked Hypophosphatemic Rickets Clinical Trials Overview The X-Linked Hypophosphatemic Rickets clinical trial report consists of 55 trials. The report provides an overview of the X-Linked Hypophosphatemic Rickets clinical trial scenario. The report provides top-line data relating to the clinical trials on X-Linked Hypophosphatemic Rickets. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trials Market Report Overview The Hypocobalaminemia (Vitamin B12) Deficiency clinical trial market research report provides an overview of the Hypocobalaminemia (Vitamin B12) Deficiency clinical trials scenario. This report provides top-line data relating to the clinical trials on Hypocobalaminemia Deficiency and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hyperphosphatemia in Chronic Kidney Disease Pipeline Products Market Report Overview Hyperphosphatemia, that is, abnormally high serum phosphate levels, can result from increased phosphate intake, decreased phosphate excretion, or a disorder that shifts intracellular phosphate to extracellular space. This condition is most commonly seen in patients with chronic kidney disease. Signs and symptoms include fatigue, nausea, sleep disturbances, shortness of breath, bone and joint pain, pruritus, and rash. Treatment includes phosphate binders and diuretics. The Hyperphosphatemia in chronic kidney disease pipeline...
-
Product Insights
Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hyperphosphatemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperphosphatemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Hyperphosphatemia – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Hyperphosphatemia - Global Clinical Trials Review, H2, 2021" provides an overview of Hyperphosphatemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperphosphatemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Avitaminosis (Hypovitaminosis) Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Avitaminosis (Hypovitaminosis) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides top line data relating to the clinical trials on Avitaminosis (Hypovitaminosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...